Neuroanatomical changes in Parkinson's disease in relation to cognition: An update.

J Adv Pharm Technol Res

Department of Physiology, Saveetha Medical College, Saveetha University, Chennai, Tamil Nadu, India.

Published: January 2016

The pathophysiological changes underlying impairment of cognition in Parkinson's disease (PD) are complex and not fully understood till date. Hence, understanding the structural changes responsible for cognitive decline in PD is essential for early diagnosis and to offer effective treatment. In this review, we discuss the neuroanatomical changes in major brain structures responsible for cognition in PD. We have included the key findings of various studies to provide up-to-date information for better understanding of pathophysiology of PD, which will help researchers and clinicians in planning and developing new treatment methods for the benefit of PD patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052937PMC
http://dx.doi.org/10.4103/2231-4040.191416DOI Listing

Publication Analysis

Top Keywords

neuroanatomical changes
8
parkinson's disease
8
changes parkinson's
4
disease relation
4
relation cognition
4
cognition update
4
update pathophysiological
4
pathophysiological changes
4
changes underlying
4
underlying impairment
4

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

UT Health San Antonio, San Antonio, TX, USA.

Background: The Amyloid-Tau-Neurodegeneration (ATN) biomarker framework for Alzheimer's disease (AD) indicates binary (presence/absence) designations for each type of pathology, without regard for anatomical distribution. Neurodegeneration is designated as positive if atrophy or hypometabolism are found on imaging. However, Clifford Jack et al.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.

Background: With a global ageing population, there is an increasing demand for fast and reliable early diagnosis of individuals. Convolutional neural networks (CNNs) have an immense potential in assisting clinicians in diagnosing dementia. Regional atrophy patterns, which are visible in T1-weighted MRI scans, have been consistently identified by the CNNs with high accuracy.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Artificial Intelligence in Biomedical Imaging Laboratory (AIBIL), Center for and Data Science for Integrated Diagnostics (AI2D), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Background: Brain aging is a complex process influenced by various genetic, lifestyle, and environmental factors, as well as by age-related and often co-existing pathologies. MRI and AI methods have been instrumental in understanding neuroanatomical changes that occur during aging in large and diverse populations.

Method: We leveraged Surreal-GAN, a state-of-the-art deep representation learning method, to elucidate the heterogeneity of brain aging by deriving dominant dimensions (patterns) of brain changes and examining their associations with various clinical and genetic factors.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Neuropsychology and Clinical Neuroscience Laboratory (LANNEC), Physiopathology Department - ICBM, Neuroscience and East Neuroscience Departments, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Background: The Alzheimer's Disease (AD) continuum is composed of Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), and Alzheimer's Disease Dementia (ADD). Changes in grey matter volume (GMV), characteristic of the AD continuum, are related to cognitive and activities of daily living (ADL) impairments. ADLs are divided into three domains: i) Basic (BADL), ii) Instrumental (IADL), and iii) Advanced (AADL), and their study is critical for understanding the evolution and adequate follow-up of patients.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, London, United Kingdom.

Background: Neuropsychiatric symptoms (NPS) are behavioural and psychological manifestations frequently present in dementia and mild cognitive impairment (MCI). NPS are known to be associated with adverse health, cognitive and functional outcomes and increasing needs for hospitalisation and institutionalisation. It is understood that MCI may be an intermediate stage between healthy and dementia states.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!